Pharmaceutical

Secured coverage for specialty pharmaceutical company under policies of general liability, products liability and management liability insurance for the defense and indemnification of claims arising out of the manufacture and sales of prescription opioid pain medication. Underlying claims included bodily injury claims by individual patients, securities class action lawsuits, Delaware Section 220 demands, shareholder derivative litigations, criminal indictments of individual officers and directors, third-party payor (health insurer) claims, and claims by local, state and national governmental entities.

Initiated litigation and rapidly settled a massive business interruption and property damage flood loss claim on behalf of a U.S. based pharmaceutical company

Litigated and negotiated defense and indemnity settlement agreement on behalf of a major life sciences company in connection with hundreds of product liability cases filed across the country alleging cancer and other adverse health effects.

Negotiated settlement with insurance carriers regarding class action lawsuits alleging injury resulting from breast cancer treatment clinical trials.

Recovered in excess of $8.4 million for defense and indemnity coverage for international pharmaceutical company subsidiary subjected to SEC enforcement action and four underlying securities fraud lawsuits.

Obtained coverage for First Party losses, government investigations and ransom payment under cyber insurance policies for company acquired by merger during pendency of cyber-attacks.

Settled event cancellation insurance claim for industry trade association.